DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis

British Journal of Surgery

Volumn 86, Issue 7, 1999, Pages 947-950

  Lindberg, J O ^a,c   Stealing, R B ^b   Rutegard J N ^b  

^a Ornskoldsviks Hospital   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c Ömsköldsvik Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ANEUPLOIDY; ARTICLE; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULCERATIVE COLITIS;

ANEUPLOIDY; COLITIS, ULCERATIVE; COLONOSCOPY; DNA; FLOW CYTOMETRY; GENETIC MARKERS; HUMANS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0032782661     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01133.x     Document Type: Article

References (13)

1. Collins RH Jr, Feldman m, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: a critical review. N Engl J Med 1987; 316: 1654-8.
2. Griffiths AM, Sherman PM. Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. J Pediatr Gastroenterol Nutr 1997; 24: 202-10.
3. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-4.
4. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-44.
5. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon AT. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34: 1075-80.
6. Shapiro BD, Lashner BA. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance. Gastrointest Endosc Clin N Am 1997; 7: 453-68.
7. Rutegård J, Stenling R. DNA content in ulcerative colitis. Hepatogastroenterology 1989; 36: 205-8.
8. Befrits R, Hammarberg C, Rubio C, Jaramillo E, Tribukait B. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 1994; 37: 313-20.
9. Löfberg R, Broström O, Karlén P, Ost A, Tribukait B. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution and relation to dysplasia. Gastroenterology 1992; 102: 1149-54.
10. Rutegård J, Åhsgren L, Stenling R, Roos G. DNA content in ulcerative colitis. Flow cytometric analysis in a patient series from a defined area. Dis Colon Rectum 1988; 31: 710-15.
11. Jonsson B, Åhsgren L, Andersson L-O, Stenling R, Rutegard J. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994; 81: 689-91.
12. Riddell RH, Goldman H, Ransohoff DH, Appelman HD, Fenoglio CM, Haggitt RC et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
13. Vindelöv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-7.